Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
RGR Sturm Ruger
- 40.040
- -0.740-1.81%
Close Feb 26 16:00 ET
- 40.040
- 0.0000.00%
Post 17:36 ET
671.15MMarket Cap22.62P/E (TTM)
40.760High39.780Low151.19KVolume40.490Open40.780Pre Close6.06MTurnover0.93%Turnover Ratio22.62P/E (Static)16.76MShares47.66852wk High2.10P/B651.67MFloat Cap34.11052wk Low0.69Dividend TTM16.28MShs Float76.395Historical High1.72%Div YieldTTM2.40%Amplitude2.295Historical Low40.080Avg Price1Lot Size
Sturm Ruger Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 63.72%55.5M | 20.59%20.02M | 308.15%9.4M | 13.38%18.74M | 39.00%7.35M | -56.10%33.9M | -38.43%16.6M | -125.25%-4.52M | 21.38%16.53M | -71.84%5.28M |
| Net income from continuing operations | -36.61%30.56M | 2.22%10.48M | -36.24%4.74M | -48.94%8.26M | -50.63%7.08M | -45.42%48.22M | -45.93%10.25M | -59.59%7.43M | -22.03%16.19M | -52.53%14.35M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 86.11%-5K | 98.04%-1K | -102.82%-2K | --0 | 60.00%-2K |
| Depreciation and amortization | -1.43%22.06M | 82.47%5.12M | -11.12%5.8M | -18.53%5.3M | -10.76%5.83M | -13.21%22.38M | -50.49%2.81M | -1.89%6.53M | -2.97%6.51M | -3.24%6.54M |
| Deferred tax | 19.81%-4.71M | 2.54%-1.76M | -76.85%-191K | 109.43%365K | -3,844.30%-3.12M | -5.28%-5.87M | 50.64%-1.81M | 94.98%-108K | -1,855.05%-3.87M | -117.83%-79K |
| Change In working capital | 107.83%2.83M | 55.75%4.72M | 86.83%-2.55M | 235.22%4.2M | 78.76%-3.54M | -7.98%-36.12M | -66.14%3.03M | -186.10%-19.39M | 79.66%-3.11M | 18.10%-16.66M |
| -Change in receivables | -230.37%-7.28M | -20,065.71%-6.99M | 40.90%-4.04M | -20.26%9.7M | -2,768.61%-5.95M | 166.39%5.59M | 100.86%35K | -33.48%-6.83M | -7.20%12.16M | 101.81%223K |
| -Change in inventory | 118.05%2.91M | 55.39%-824K | 67.43%-3.21M | 41.44%-4.37M | 272.42%11.31M | 25.50%-16.13M | 53.70%-1.85M | -126.03%-9.86M | 27.07%-7.46M | 199.15%3.04M |
| -Change in payables and accrued expense | 186.00%3.79M | 57.50%4.3M | 820.77%2.26M | 88.31%-713K | -183.72%-2.06M | -588.44%-4.41M | -41.56%2.73M | -107.20%-313K | 51.84%-6.1M | -124.13%-725K |
| -Change in other current liabilities | -150.54%-188K | -29.39%161K | 20.00%-44K | 118.18%6K | -234.05%-311K | 163.70%372K | 193.44%228K | -685.71%-55K | 25.00%-33K | 180.28%232K |
| -Change in other working capital | 116.69%3.6M | 328.94%8.06M | 206.52%2.48M | 75.16%-416K | 66.36%-6.53M | -892.08%-21.55M | -85.06%1.88M | -42.33%-2.33M | 69.24%-1.68M | -153.00%-19.42M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 63.72%55.5M | 20.59%20.02M | 308.15%9.4M | 13.38%18.74M | 39.00%7.35M | -56.10%33.9M | -38.43%16.6M | -125.25%-4.52M | 21.38%16.53M | -71.84%5.28M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -133.75%-13.79M | -5,404.15%-10.62M | -74.97%3.25M | -3.04%-7.63M | -96.58%1.21M | 209.30%40.86M | 95.50%-193K | 511.46%13M | -575.59%-7.41M | 85.63%35.46M |
| Net PPE purchase and sale | -31.81%-20.82M | 12.84%-3.63M | -0.27%-6.78M | -167.81%-8.63M | -8.23%-1.79M | 43.04%-15.8M | 60.48%-4.16M | -135.19%-6.76M | 6.61%-3.22M | 84.82%-1.65M |
| Net investment purchase and sale | -87.59%7.03M | -276.45%-7M | -49.22%10.04M | 123.80%996K | -91.92%3M | 38.71%56.65M | -35.78%3.97M | 6,515.58%19.76M | -183.85%-4.18M | 23.76%37.11M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | -95.00%5K | --0 | -92.00%2K | --0 | --3K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -133.75%-13.79M | -5,404.15%-10.62M | -74.97%3.25M | -3.04%-7.63M | -96.58%1.21M | 209.30%40.86M | 95.50%-193K | 511.46%13M | -575.59%-7.41M | 85.63%35.46M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 62.44%-46.86M | 53.42%-6.89M | -92.51%-12.28M | -245.52%-19.76M | 91.90%-7.92M | -169.39%-124.76M | -101.05%-14.8M | 24.15%-6.38M | 56.74%-5.72M | -465.05%-97.86M |
| Net common stock issuance | -191.32%-34.41M | 57.22%-5.05M | ---9.08M | ---17.06M | ---3.22M | -5,220.27%-11.81M | -10,170.43%-11.81M | --0 | --0 | --0 |
| Cash dividends paid | 89.32%-11.83M | 38.37%-1.84M | 49.80%-3.2M | 52.23%-2.71M | 95.74%-4.08M | -159.35%-110.79M | 58.81%-2.98M | 23.17%-6.38M | 52.79%-5.67M | -531.44%-95.76M |
| Net other financing activities | 71.06%-624K | --0 | --0 | --0 | 70.33%-624K | 36.04%-2.16M | --0 | --0 | 95.65%-53K | 2.37%-2.1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 62.44%-46.86M | 53.42%-6.89M | -92.51%-12.28M | -245.52%-19.76M | 91.90%-7.92M | -169.39%-124.76M | -101.05%-14.8M | 24.15%-6.38M | 56.74%-5.72M | -465.05%-97.86M |
| Net cash flow | ||||||||||
| Beginning cash position | -76.72%15.17M | -44.52%7.52M | -37.56%7.15M | 96.31%15.81M | -76.72%15.17M | 209.70%65.17M | -72.80%13.56M | -73.69%11.46M | -80.64%8.05M | 209.70%65.17M |
| Current changes in cash | 89.71%-5.15M | 55.17%2.51M | -82.45%369K | -354.23%-8.65M | 101.11%633K | -213.30%-50M | -89.46%1.62M | -66.69%2.1M | 74.30%3.4M | -378.07%-57.12M |
| End cash Position | -33.91%10.03M | -33.91%10.03M | -44.52%7.52M | -37.56%7.15M | 96.31%15.81M | -76.72%15.17M | -76.72%15.17M | -72.80%13.56M | -73.69%11.46M | -80.64%8.05M |
| Free cash flow | 91.57%34.68M | 31.76%16.4M | 123.19%2.62M | -24.00%10.11M | 53.00%5.56M | -63.42%18.11M | -24.32%12.44M | -175.15%-11.28M | 30.87%13.31M | -53.91%3.63M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
